Table 1 Clinical sample overview and patients demographics
Cohort | Samples | No. of subjects | Mean age (range) | Gender, % females | Tumor stage I | Tumor stage II | Tumor stage III | Tumor stage IV |
|---|---|---|---|---|---|---|---|---|
1 | NSCLC patients | 8 | 61 (47–77) | 12.8 | 1 | 2 | 3 | 2 |
1 | IPF patients | 8 | 74 (55–82) | 62.5 | - | - | - | - |
1 | COPD patients | 8 | 75 (69–82) | 50.0 | - | - | - | - |
1 | Colonoscopy-negative controls | 8 | 55 (44–65) | 75.0 | - | - | - | - |
1 | Healthy controls | 20 | 34 (20–51) | 10.0 | - | - | - | - |
2 | NSCLC patientsa | 12 | 60 (47–80) | 25.0 | 5 | 2 | 4 | - |
2 | SCLC patients | 8 | 61 (54–82) | 25.0 | 3 | 1 | 4 | - |
2 | Healthy controls | 43 | 71 (60–82) | 100.0 | - | - | - | - |
3 | IPF patients | 116 | 65 (43–80) | 21.5 | - | - | - | - |
3 | Healthy controls | 38 | 34 (20–58) | 10.5 | - | - | - | - |